Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Everything You Need to Know About Moderna's Valuation


Shares of Moderna (NASDAQ: MRNA) have more than tripled so far this year as the biotech has quickly pushed its coronavirus vaccine, mRNA-1273, through the clinical trial process.

MRNA Chart

MRNA data by YCharts

Continue reading


Source Fool.com

Like: 0
Share

Comments